Genetics Institute of America is at the forefront of PD-L1/PD-1 immunotherapy testing. Our extensive offering, pathology expertise, and flexible testing options make us an ideal partner for your testing needs.
One major advantage of immunotherapies over traditional cancer treatments that involve radiation and conventional chemotherapy is that immunotherapies are generally much less harmful to human tissue, thus reducing the side effect burden. Today, a number of checkpoint inhibitors have been clinically approved for the treatment of melanoma, lung cancer, renal cancer, and lymphoma. A large number of checkpoint therapy trials are currently under way against most cancer types.
What We Offer
Your patient's health is your most important asset. You should entrust it only to the best professionals.
Timely Analysis & Reports
Due to our research findings and technology, we are able to provide timely reports of genetic and specialty testing.
Quality and Safety
All scientists and personnel at Genetics Institute of America have been trained thoroughly to assist in any situation.
Our panels are designed for steady progress, with every phase promptly implemented.
Speak to one of our representatives today to learn more about enrolling your practice.
Get News & Updates
Sign up for important updates and additional information from our Care Coordinators.